- Home
- ATXI vs LGHL Comparison
ATXI vs LGHL Comparison
Compare ATXI & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXI
- LGHL
- Stock Information
- Founded
- ATXI 2015
- LGHL 2015
- Country
- ATXI United States
- LGHL Singapore
- Employees
- ATXI N/A
- LGHL N/A
- Industry
- ATXI Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- ATXI Health Care
- LGHL Finance
- Exchange
- ATXI Nasdaq
- LGHL Nasdaq
- Market Cap
- ATXI 3.7M
- LGHL 4.3M
- IPO Year
- ATXI 2017
- LGHL N/A
- Fundamental
- Price
- ATXI $1.36
- LGHL $0.15
- Analyst Decision
- ATXI
- LGHL
- Analyst Count
- ATXI 0
- LGHL 0
- Target Price
- ATXI N/A
- LGHL N/A
- AVG Volume (30 Days)
- ATXI 1.1M
- LGHL 1.9M
- Earning Date
- ATXI 03-17-2025
- LGHL 03-04-2025
- Dividend Yield
- ATXI N/A
- LGHL N/A
- EPS Growth
- ATXI N/A
- LGHL N/A
- EPS
- ATXI N/A
- LGHL N/A
- Revenue
- ATXI N/A
- LGHL $13,659,110.00
- Revenue This Year
- ATXI N/A
- LGHL N/A
- Revenue Next Year
- ATXI N/A
- LGHL N/A
- P/E Ratio
- ATXI N/A
- LGHL N/A
- Revenue Growth
- ATXI N/A
- LGHL 11.35
- 52 Week Low
- ATXI $1.22
- LGHL $0.13
- 52 Week High
- ATXI $15.00
- LGHL $1.14
- Technical
- Relative Strength Index (RSI)
- ATXI 41.78
- LGHL 50.11
- Support Level
- ATXI $1.33
- LGHL $0.14
- Resistance Level
- ATXI $1.44
- LGHL $0.15
- Average True Range (ATR)
- ATXI 0.09
- LGHL 0.01
- MACD
- ATXI 0.02
- LGHL 0.00
- Stochastic Oscillator
- ATXI 63.64
- LGHL 46.19
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.